drugset / Trial / NCT01609907

Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan

NCT01609907

Phase 1 Completed 30 enrolled Yuhan Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of this study is to compare pharmacokinetics after single oral administration of rosuvastatin and valsartan each separately versus coadministration of rosuvastatin and valsartan in healthy male volunteers.

Timeline

Start
2011-11
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 20 mg Oral
Subject Valsartan Small molecule 160 mg Oral